Chronic granulomatous disease with recurrent hepatic abscesses in an adult

Saudi Medical Journal

Volumn 28, Issue 10, 2007, Pages 1593-1596

  Al Khuwaitir, Tarig S ^a   Madani, Tariq A ^b   Al Qahtani, Tariq ^a   Al Tuwaijri, Ali S ^c  

^a Riyadh Medical Complex   (Saudi Arabia)

^b KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

^c KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFALOTIN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; FLUCLOXACILLIN; FLUCONAZOLE; GAMMA1B INTERFERON; METRONIDAZOLE; VANCOMYCIN;

ABSCESS DRAINAGE; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOGRAPHY; EPILEPSY; FEMALE; HISTOPATHOLOGY; HUMAN; KLEBSIELLA PNEUMONIAE; LIVER ABSCESS; NEUTROPHILIA; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; RECURRENT DISEASE; SKIN ABSCESS; STAPHYLOCOCCUS AUREUS; THRUSH;

ADULT; FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; LIVER ABSCESS; RECURRENCE;

EID: 35948991104     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Gallin JI, Alling DW, Malech HL, Wesley R, Koziol D, Marciano B, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 2003; 348: 2416-2422.
2. Lublin M, Bartlett DL, Danforth DN, Kauffman H, Gallin JI, Malech HL, et al. Hepatic abscesses in patients with chronic granulomatous disease. Ann Surg 2002; 235: 383-391.
3. Clark RA, Malech HL, Gallin JI, Nunoi H, Volpp BD, Pearson DW, et al. Genetic variants of chronic granulomatous disease: Prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. N Eng J Med 1989; 321: 647-652.
4. Chen LE, Minkes RK, Shackelford PG, Strasberg SM, Kuo EY, Langer JC. Cut it out: Managing hepatic abscesses in patients with chronic granulomatous disease. J Pediatr Surg 2003; 38: 709-713.
5. Nauseff WM, Clark RA. Graulocytic Phagocytes. In: Mandell GL, Benett JE, Dolin R, editors. Mandell, Douglas and Benett's Principals and Practice of Infectious Diseases. 5th ed. New York (NY): Churchill Livingston; 2000. p.102-103.
6. Goldstein MA, Harden CL. Infectious states. In: Ettinger AB, Devinsky O, editors. Managing epilepsy and co-existing disorders. Boston (MA): Butterworth-Heinemann; 2002. p. 83-133.
7. Conte D, Fraquelli M, Capsoni F, Giacca M, Zentillin L, Bardella MT. Effectiveness of IFN-gamma for liver abscesses in chronic granulomatous disease. J Interferon Cytokine Res 1999; 19: 705-710.
8. Martino S, Ciocchini M, Marmont A, Madon E, Tovo PA. Treatment of hepatic abscesses in chronic granulomatous disease with granulocyte-macrophage colony-stimulating factor. Clin Infect Dis 2000; 30: 222-223.
9. Alberti D, Borsellino A, Locatelli C, Nani R, Cheli M, Torre G, et al. Percutaneous transhepatic alcoholization: A new therapeutic strategy in children with chronic granulomatous disease and liver abscess. Pediatr Infect Dis J 2002; 21: 1081-1083.